Agios Pharmaceuticals to Present at the Cowen and Company 34th Annual Health Care Conference

Agios Pharmaceuticals to Present at the Cowen and Company 34th Annual Health Care Conference

[Business Wire] – Agios Pharmaceuticals, Inc. , a leader in the fields of cancer metabolism and inborn errors of metabolism, today announced that David Schenkein, M.D., chief executive more

View todays social media effects on AGIO

View the latest stocks trending across Twitter. Click to view dashboard

See who Agios is hiring next, click here to view

Share this post